NEUROFIBROMATOSIS TYPE-2 WITHOUT VESTIBULAR SCHWANNOMA

被引:0
|
作者
MAUTNER, VF
LINDENAU, M
KOPPEN, J
HAZIM, W
KLUWE, L
机构
[1] ALLGEMEINES KRANKENHAUS OCHSENZOLL,NEUROL ABT,HAMBURG,GERMANY
[2] UNIV HAMBURG,KRANKENHAUS EPPENDORF,NEUROCHIRURG KLIN,W-2000 HAMBURG,GERMANY
[3] UNIV HAMBURG,HOSP EPPENDORF,AUGENKLIN,PLEOPT & ORTHOPT ABT,HAMBURG,GERMANY
来源
ZENTRALBLATT FUR NEUROCHIRURGIE | 1995年 / 56卷 / 02期
关键词
NEUROFIBROMATOSIS TYPE 2; MUTATION ANALYSIS; CHROMOSOME; 22; LINKAGE ANALYSIS; ATYPICAL NEUROFIBROMATOSIS TYPE 2; VESTIBULAR SCHWANNOMA;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Bilateral vestibular schwannomas (VSs) are the hallmark of neurofibromatosis type 2 and the crucial criteria for the diagnosis of this autosomal dominant disorder according to the criteria of the National Institutes of Health Consensus Statement. We describe three patients without VSs aged 47, 52 and 69 years, in whom a NF2 gene carrier status was diagnosed by spinal tumors, a cataract and schwannoma of cranial and peripheral nerves. In one case the diagnosis was ascertained by mutation analysis, which revealed a 163bp deletion in the NF2 cDNA, and by the fact that two daughters had the same deletion and NF2 according to the NIH criteria. Our finding suggests that patients with spinal tumors, multiple brain tumors, associated neurinomas or cataract might be carriers of a mutated NF2-gene. The study suggests that the NIH criteria are too restrictive, since NF2 seems to show up for a broader spectrum of phenotypes.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [31] Pediatric vestibular schwannoma with or without neurofibromatosis: Characteristic features and operative nuances
    Garg, Pallav
    Behari, Sanjay
    Jaiswal, Shishir
    Jaiswal, Awadesh
    Jain, Vijendra K.
    Mahapatra, Ashok K.
    JOURNAL OF PEDIATRIC NEUROSCIENCES, 2007, 2 (02) : 58 - 66
  • [32] Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
    Plotkin, Scott R.
    Halpin, Chris
    McKenna, Michael J.
    Loeffler, Jay S.
    Batchelor, Tracy T.
    Barker, Fred G., II
    OTOLOGY & NEUROTOLOGY, 2010, 31 (07) : 1135 - 1143
  • [33] NEUROFIBROMATOSIS TYPE-2
    EVANS, DGR
    HARRIS, R
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 26 - 30
  • [34] Complete surgical excision of intramedullary schwannoma at the craniovertebral junction in neurofibromatosis type-2
    Siddiqui, AA
    Shah, AA
    BRITISH JOURNAL OF NEUROSURGERY, 2004, 18 (02) : 193 - 196
  • [35] NEUROFIBROMATOSIS TYPE-2
    THOMAS, G
    MEREL, P
    SANSON, M
    HOANGXUAN, K
    ZUCMAN, J
    DESMAZE, C
    MELOT, T
    AURIAS, A
    DELATTRE, O
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (13) : 1981 - 1987
  • [36] BEVACIZUMAB IS EFFECTIVE TO CONTROL THE GROWTH OF VESTIBULAR SCHWANNOMA IN A PEDIATRIC CASE WITH NEUROFIBROMATOSIS TYPE 2
    Fujiki, Toshihiro
    Takenaka, Mika
    Sakai, Yuta
    Noguchi, Kazuhiro
    Ikawa, Yasuhiro
    Wada, Taizo
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [37] Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
    Kim, Junhyung
    Byeon, Yukyeng
    Song, Sang Woo
    Cho, Young Hyun
    Hong, Chang-Ki
    Hong, Seok Ho
    Kim, Jeong Hoon
    Lee, Do Heui
    Park, Ji Eun
    Kim, Ho Sung
    Kim, Young-Hoon
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Vestibular schwannoma growth rates in Neurofibromatosis type 2 Natural History consortium subjects
    Slattery, WH
    Fisher, LM
    Iqbal, Z
    Oppenhiemer, M
    OTOLOGY & NEUROTOLOGY, 2004, 25 (05) : 811 - 817
  • [39] Prospective study to evaluate the role of bevacizumab in treatment of vestibular schwannoma in neurofibromatosis type 2
    Pavana, V
    Agarwal, Deepak
    Doddamani, Ramesh
    ANNALS OF ONCOLOGY, 2023, 34 : S1411 - S1412
  • [40] Serial analysis of gene expression in neurofibromatosis type 2-associated vestibular schwannoma
    Halum, SL
    Popper, P
    Cioffi, JA
    Wackym, PA
    OTOLOGY & NEUROTOLOGY, 2004, 25 (04) : 587 - 593